Neoadjuvant chemoradiotherapy adjuvant. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Esophagogastric Junction Lymph Nodes Larynx Axilla

Diseases46

Rectal Neoplasms Esophageal Neoplasms Adenocarcinoma Carcinoma, Squamous Cell Neoplasm Recurrence, Local Head and Neck Neoplasms Breast Neoplasms Nasopharyngeal Neoplasms Lymphatic Metastasis Lung Neoplasms Hypopharyngeal Neoplasms Carcinoma, Non-Small-Cell Lung Pancreatic Neoplasms Muscle Neoplasms Radiation Injuries Laryngeal Neoplasms Neoplasm, Residual Uterine Cervical Neoplasms Deglutition Disorders Carcinoma Oropharyngeal Neoplasms Mucositis Stomach Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Urinary Bladder Neoplasms Anus Neoplasms Carcinoma, Ductal, Breast Sarcoma Esophagitis Otorhinolaryngologic Neoplasms Osteosarcoma Pelvic Neoplasms Carcinoma, Lobular Leukopenia Disease Progression Bone Neoplasms Carcinoma, Transitional Cell Radiation Pneumonitis Stomatitis Voice Disorders Carcinoma, Small Cell Recurrence Neoplasms, Squamous Cell Brain Neoplasms Postoperative Complications

Chemicals and Drugs50

Fluorouracil Cisplatin Adjuvants, Immunologic Taxoids Deoxycytidine Antineoplastic Agents Freund's Adjuvant Antimetabolites, Antineoplastic Paclitaxel Epirubicin Doxorubicin Carboplatin Cyclophosphamide Organoplatinum Compounds Leucovorin Fluorodeoxyglucose F18 Anthracyclines Adjuvants, Pharmaceutic Tumor Markers, Biological Vinblastine Tegafur Receptor, erbB-2 Antibodies, Monoclonal, Humanized Antineoplastic Agents, Hormonal Radiopharmaceuticals Oxonic Acid Radiation-Sensitizing Agents Receptors, Estrogen Hydroxyurea Methotrexate Mitomycin Ifosfamide Receptors, Progesterone Ki-67 Antigen Biomarkers, Pharmacological Etoposide Nitriles Tamoxifen Antineoplastic Agents, Alkylating Bridged Compounds Camptothecin Triazoles Vincristine Dacarbazine Antibodies, Monoclonal Antineoplastic Agents, Phytogenic Androgen Antagonists Aluminum Hydroxide Aromatase Inhibitors Goserelin

Analytical, Diagnostic and Therapeutic Techniques and Equipment67

Neoadjuvant Therapy Chemoradiotherapy, Adjuvant Chemoradiotherapy Esophagectomy Radiotherapy, Adjuvant Chemotherapy, Adjuvant Combined Modality Therapy Treatment Outcome Neoplasm Staging Disease-Free Survival Antineoplastic Combined Chemotherapy Protocols Survival Rate Prognosis Survival Analysis Retrospective Studies Kaplan-Meier Estimate Radiotherapy Dosage Radiotherapy Dose Fractionation Follow-Up Studies Induction Chemotherapy Drug Administration Schedule Positron-Emission Tomography Preoperative Care Radiotherapy, Conformal Digestive System Surgical Procedures Cystectomy Organ Sparing Treatments Remission Induction Lymph Node Excision Brachytherapy Prospective Studies Gastrectomy Radiotherapy, Intensity-Modulated Feasibility Studies Predictive Value of Tests Tomography, X-Ray Computed Randomized Controlled Trials as Topic Multimodal Imaging Clinical Trials, Phase II as Topic Multivariate Analysis Clinical Trials as Topic Proportional Hazards Models Pneumonectomy Tumor Burden Postoperative Care Immunohistochemistry Radiotherapy, High-Energy Mastectomy Laryngectomy Salvage Therapy Treatment Failure Neoplasm Grading Patient Selection Risk Assessment Mastectomy, Segmental Radiation Dosage Lymphatic Irradiation Magnetic Resonance Imaging Infusions, Intravenous Clinical Trials, Phase III as Topic Maximum Tolerated Dose Biopsy Endosonography Risk Factors Postoperative Period Transplantation, Autologous

Phenomena and Processes3

Time Factors Radiation Dosage Maximum Tolerated Dose

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science3

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated

Health Care25

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Preoperative Care Radiation Injuries Prospective Studies Feasibility Studies Predictive Value of Tests Randomized Controlled Trials as Topic Clinical Trials, Phase II as Topic Multivariate Analysis Clinical Trials as Topic Proportional Hazards Models Postoperative Care Treatment Failure Patient Selection Risk Assessment Radiation Dosage Clinical Trials, Phase III as Topic Risk Factors Postoperative Period

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Neoadjuvant Therapy Chemoradiotherapy, Adjuvant Chemoradiotherapy Esophagectomy Radiotherapy, Adjuvant Rectal Neoplasms Chemotherapy, Adjuvant Esophageal Neoplasms Combined Modality Therapy Fluorouracil Treatment Outcome Neoplasm Staging Adenocarcinoma Carcinoma, Squamous Cell Disease-Free Survival Antineoplastic Combined Chemotherapy Protocols Neoplasm Recurrence, Local Survival Rate Prognosis Survival Analysis Cisplatin Retrospective Studies Kaplan-Meier Estimate Adjuvants, Immunologic Radiotherapy Dosage Head and Neck Neoplasms Breast Neoplasms Taxoids Deoxycytidine Radiotherapy Antineoplastic Agents Freund's Adjuvant Dose Fractionation Nasopharyngeal Neoplasms Antimetabolites, Antineoplastic Paclitaxel Follow-Up Studies Epirubicin Doxorubicin Induction Chemotherapy Drug Administration Schedule Carboplatin Lymphatic Metastasis Positron-Emission Tomography Preoperative Care Lung Neoplasms Cyclophosphamide Organoplatinum Compounds Radiotherapy, Conformal Leucovorin Fluorodeoxyglucose F18 Digestive System Surgical Procedures Cystectomy Hypopharyngeal Neoplasms Esophagogastric Junction Organ Sparing Treatments Carcinoma, Non-Small-Cell Lung Remission Induction Pancreatic Neoplasms Muscle Neoplasms Lymph Node Excision Brachytherapy Anthracyclines Radiation Injuries Laryngeal Neoplasms Prospective Studies Neoplasm, Residual Uterine Cervical Neoplasms Adjuvants, Pharmaceutic Tumor Markers, Biological Gastrectomy Time Factors Deglutition Disorders Carcinoma Radiotherapy, Intensity-Modulated Vinblastine Feasibility Studies Tegafur Oropharyngeal Neoplasms Receptor, erbB-2 Antibodies, Monoclonal, Humanized Antineoplastic Agents, Hormonal Radiopharmaceuticals Predictive Value of Tests Tomography, X-Ray Computed Mucositis Oxonic Acid Randomized Controlled Trials as Topic Radiation-Sensitizing Agents Stomach Neoplasms Receptors, Estrogen Multimodal Imaging Clinical Trials, Phase II as Topic Multivariate Analysis Neoplasm Metastasis Hydroxyurea Neoplasm Invasiveness Urinary Bladder Neoplasms Methotrexate Clinical Trials as Topic

No FAQ available that match "neoadjuvant chemoradiotherapy adjuvant"